Mechanism of Action of Rifampin on Mycobacterium Smegmatis

Overview

Journal J Bacteriol

Publisher American Society for Microbiology

Specialty Microbiology

Date 1971 Nov 1

PMID 4942761

Citations 14

Authors

R J White

G C LANCINI

L G Silvestri

Affiliations

Soon will be listed here.

Abstract

Deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase (EC 2.7.7.6) isolated from a rifampin-sensitive strain of Mycobacterium smegmatis was 90% inhibited by 1 mug of rifampin per ml; enzyme from a rifampin-resistant mutant was not affected by this concentration of antibiotic. Inhibition of phenylalanine-1-(14)C incorporation by rifampin in growing cultures was complete about 6 min after addition of antibiotic. Under the same conditions, uracil-2-(14)c incorporated was blocked after 1.5 to 2 min. Rifampin kills M. smegmatis very slowly. When rifampin-inhibited cultures were transferred to a rifampin-free medium, there was a partial resumption of uracil-2-(14)C incorporation, even in the presence of chloramphenicol. We conclude that a primary event in the inhibition of M. smegmatis by rifampin is the block of DNA-dependent RNA polymerase.

Citing Articles

Lsr2 and Its Novel Paralogue Mediate the Adjustment of Mycobacterium smegmatis to Unfavorable Environmental Conditions.

Kolodziej M, Lebkowski T, Plocinski P, Holowka J, Pasciak M, Wojtas B mSphere. 2021; 6(3).

PMID: 33980681 PMC: 8125055. DOI: 10.1128/mSphere.00290-21.

COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.

Verma Y, Verma R, Tyagi N, Behl A, Kumar S, Gangenahalli G Stem Cell Rev Rep. 2020; 17(1):113-131.

PMID: 32920752 PMC: 7486977. DOI: 10.1007/s12015-020-10037-2.

Cure of tuberculosis using nanotechnology: An overview.

Kerry R, Gouda S, Sil B, Das G, Shin H, Ghodake G J Microbiol. 2018; 56(5):287-299.

PMID: 29721825 DOI: 10.1007/s12275-018-7414-y.

Structure and activity of lobophorins from a turrid mollusk-associated Streptomyces sp.

Lin Z, Koch M, Pond C, Mabeza G, Seronay R, Concepcion G J Antibiot (Tokyo). 2013; 67(1):121-6.

PMID: 24220110 PMC: 4470571. DOI: 10.1038/ja.2013.115.

Rapid radiometric method of testing susceptibility of mycobacteria and slow-growing fungi to antimicrobial agents.

Benitez P, Medoff G, Kobayashi G Antimicrob Agents Chemother. 1974; 6(1):29-33.

PMID: 15828167 PMC: 429043. DOI: 10.1128/AAC.6.1.29.

References

Sonenshein A, Losick R . RNA polymerase mutants blocked in sporulation. Nature. 1970; 227(5261):906-9. DOI: 10.1038/227906a0. View

Gray W, Midgley J . The control of ribonucleic acid synthesis in bacteria. The synthesis and stbility of ribonucleic acid in rifampicin-inhibited cultures of Escherichia coli. Biochem J. 1971; 122(2):161-9. PMC: 1176759. DOI: 10.1042/bj1220161. View

Arioli V, PALLANZA R, FURESZ S, Carniti G . Rifampicin: a new rifamycin. I. Bacteriological studies. Arzneimittelforschung. 1967; 17(5):523-9. View

Burgess R . A new method for the large scale purification of Escherichia coli deoxyribonucleic acid-dependent ribonucleic acid polymerase. J Biol Chem. 1969; 244(22):6160-7. View

Wehrli W, KNUSEL F, STAEHELIN M . Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria. Biochem Biophys Res Commun. 1968; 32(2):284-8. DOI: 10.1016/0006-291x(68)90382-3. View

PALLANZA R, Arioli V, FURESZ S, Bolzoni G . Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations. Arzneimittelforschung. 1967; 17(5):529-34. View

Reid P, Speyer J . Rifampicin inhibition of ribonucleic acid and protein synthesis in normal and ethylenediaminetetraacetic acid-treated Escherichia coli. J Bacteriol. 1970; 104(1):376-89. PMC: 248224. DOI: 10.1128/jb.104.1.376-389.1970. View

Doi R, Brown L, Rodgers G, Hsu Y . Bacillus subtilis mutant altered in spore morphology and in RNA polymerase activity. Proc Natl Acad Sci U S A. 1970; 66(2):404-10. PMC: 283059. DOI: 10.1073/pnas.66.2.404. View

Tocchini-Valentini G, Marino P, COLVILL A . Mutant of E. coli containing an altered DNA-dependent RNA polymerase. Nature. 1968; 220(5164):275-6. DOI: 10.1038/220275a0. View

10.

LANCINI G, Sartori G . Rifamycins LXI: in vivo inhibition of RNA synthesis of rifamycins. Experientia. 1968; 24(11):1105-6. DOI: 10.1007/BF02147783. View

11.

Rees R, Pearson J, Waters M . Experimental and clinical studies on rifampicin in treatment of leprosy. Br Med J. 1970; 1(5688):89-92. PMC: 1699176. DOI: 10.1136/bmj.1.5688.89. View

12.

Hartmann G, Honikel K, KNUSEL F, Nuesch J . The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta. 1967; 145(3):843-4. DOI: 10.1016/0005-2787(67)90147-5. View

13.

Lancini G, PALLANZA R, Silvestri L . Relationships between bactericidal effect and inhibition of ribonucleic acid nucleotidyltransferase by rifampicin in Escherichia coli K-12. J Bacteriol. 1969; 97(2):761-8. PMC: 249757. DOI: 10.1128/jb.97.2.761-768.1969. View

14.

EZEKIEL D, Hutchins J . Mutations affecting RNA polymerase associated with rifampicin resistance in Escherichia coli. Nature. 1968; 220(5164):276-7. DOI: 10.1038/220276a0. View

15.

Rabussay D, Zillig W . A rifampicin resistent rna-polymerase from E. coli altered in the beta-subunit. FEBS Lett. 1969; 5(2):104-106. DOI: 10.1016/0014-5793(69)80305-4. View

16.

SENSI P, MARGALITH P, TIMBAL M . Rifomycin, a new antibiotic; preliminary report. Farmaco Sci. 1959; 14(2):146-7. View